Levoxyl and Micro-k drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levoxyl (levothyroxine sodium) and Micro-k (potassium chloride). Common drug interactions include drug hypersensitivity among females and embolism among males.

The phase IV clinical study analyzes what interactions people have when they take Levoxyl and Micro-k. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Levoxyl?

Levoxyl has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 25,178 Levoxyl users. Check the latest studies of Levoxyl.

What is Micro-k?

Micro-k has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 1,895 Micro-k users. Check the latest studies of Micro-k.



On Jul, 18, 2026

34 people who take Levoxyl and Micro-k together, and have interactions are studied.

Levoxyl and Micro-k drug interactions.

What are the common drug interactions of Levoxyl and Micro-K, by gender? *:

female:

  1. Drug hypersensitivity
  2. Drug toxicity
  3. Dry skin
  4. Eating disorder
  5. Endocarditis (inflammation in heart muscle)
  6. Excoriation (to tear or wear off the skin of)
  7. Fluid retention (an abnormal accumulation of fluid in the blood)
  8. Gastric haemorrhage (bleeding stomach)
  9. Hallucination (an experience involving the perception of something not present)
  10. Anaemia (lack of blood)

male:

  1. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  2. Pleural effusion (water on the lungs)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Gout (uric acid crystals building up in the body)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Syncope (loss of consciousness with an inability to maintain postural tone)
  9. Pneumonia
  10. Anxiety

What are the common drug interactions of Levoxyl and Micro-K, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  2. Pleural effusion (water on the lungs)
  3. Pneumonia
  4. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  5. Pulmonary embolism (blockage of the main artery of the lung)

40-49:

  1. Chest pain
  2. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Gout (uric acid crystals building up in the body)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

50-59:

  1. Abdominal pain
  2. Anaemia (lack of blood)
  3. Arthralgia (joint pain)
  4. Blood glucose increased
  5. Breast cancer
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Drug ineffective
  8. Fall
  9. Nausea (feeling of having an urge to vomit)
  10. Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)

60+:

  1. Benign lymph node neoplasm (benign (non-cancerous) tumours of the lymph node)
  2. Blepharospasm (any abnormal contraction or twitch of the eyelid)
  3. Facial palsy (paralysis of face nerve)
  4. Gingival ulceration (ulcer on gums)
  5. Inflammation
  6. Joint range of motion decreased (disease of joint movement)
  7. Lymphoedema (localized fluid retention and tissue swelling)
  8. Mobility decreased (ability to move is reduced)
  9. Muscle spasms (muscle contraction)
  10. Muscular weakness (muscle weakness)

What are the existing conditions these people have? *

  1. High Blood Pressure: 6 people, 17.65%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 14.71%
  3. Osteoporosis (bones weak and more likely to break): 5 people, 14.71%
  4. Breast Cancer: 4 people, 11.76%
  5. High Blood Cholesterol: 4 people, 11.76%
  6. Pain: 3 people, 8.82%
  7. Gastric Ulcer (stomach ulcer): 2 people, 5.88%
  8. Anaemia (lack of blood): 2 people, 5.88%
  9. Breast Cancer Metastatic: 2 people, 5.88%
  10. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Levoxyl and Micro-k?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levoxyl and Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levoxyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Micro-k:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levoxyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micro-k and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and potassium chloride (the active ingredients of Levoxyl and Micro-k, respectively), and Levoxyl and Micro-k (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: